tiprankstipranks
Trending News
More News >
Neuroscientific Biopharmaceuticals Ltd. (AU:NSB)
ASX:NSB
Australian Market
Advertisement

Neuroscientific Biopharmaceuticals Ltd. (NSB) Price & Analysis

Compare
4 Followers

NSB Stock Chart & Stats


Neuroscientific Biopharmaceuticals Ltd. News

NSB FAQ

What was Neuroscientific Biopharmaceuticals Ltd.’s price range in the past 12 months?
Neuroscientific Biopharmaceuticals Ltd. lowest share price was AU$0.03 and its highest was AU$0.26 in the past 12 months.
    What is Neuroscientific Biopharmaceuticals Ltd.’s market cap?
    Neuroscientific Biopharmaceuticals Ltd.’s market cap is AU$56.54M.
      When is Neuroscientific Biopharmaceuticals Ltd.’s upcoming earnings report date?
      Neuroscientific Biopharmaceuticals Ltd.’s upcoming earnings report date is Mar 04, 2026 which is in 178 days.
        How were Neuroscientific Biopharmaceuticals Ltd.’s earnings last quarter?
        Neuroscientific Biopharmaceuticals Ltd. released its earnings results on Aug 28, 2025. The company reported -AU$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.01.
          Is Neuroscientific Biopharmaceuticals Ltd. overvalued?
          According to Wall Street analysts Neuroscientific Biopharmaceuticals Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Neuroscientific Biopharmaceuticals Ltd. pay dividends?
            Neuroscientific Biopharmaceuticals Ltd. does not currently pay dividends.
            What is Neuroscientific Biopharmaceuticals Ltd.’s EPS estimate?
            Neuroscientific Biopharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Neuroscientific Biopharmaceuticals Ltd. have?
            Neuroscientific Biopharmaceuticals Ltd. has 332,575,700 shares outstanding.
              What happened to Neuroscientific Biopharmaceuticals Ltd.’s price movement after its last earnings report?
              Neuroscientific Biopharmaceuticals Ltd. reported an EPS of -AU$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Neuroscientific Biopharmaceuticals Ltd.?
                Currently, no hedge funds are holding shares in AU:NSB

                Company Description

                Neuroscientific Biopharmaceuticals Ltd.

                Neuroscientific Biopharmaceuticals Ltd. (NSB) is a biotechnology company specializing in the development of novel peptide-based pharmaceutical products targeting neurodegenerative conditions. The company operates within the pharmaceutical and biotechnology sectors, focusing on creating innovative therapies for diseases such as Alzheimer's, Parkinson's, and Multiple Sclerosis. NSB's core product portfolio includes patented compounds aimed at enhancing neuron survival and regeneration.

                Neuroscientific Biopharmaceuticals Ltd. (NSB) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Cynata Therapeutics Limited
                Prescient Therapeutics Limited
                Starpharma Holdings Limited
                Island Pharmaceuticals Ltd
                AnteoTech Ltd

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis